homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

April 30, 2020

Avalyn Pharma

Seattle-based Avalyn Pharma secured $35.5 million in Series B financing led by Norwest Venture Partners. Others participating in the financing included Pivotal bioVenture Partners, F-Prime Capital, Novo Holdings, RiverVest Venture Partners and TPG Biotech. Concurrent with the financing, venture capitalists Dr. Robert Mittendorff of Norwest and Dr. Heather Preston of Pivotal joined Avalyn's board. Avalyn is working on therapeutic programs for pulmonary fibrosis and chronic lung allograft dysfunction.




Email or user name:
Password:
 
Forgot password? Click here.